The effect of nitric oxide surface flux on the foreign body response to subcutaneous implants

Biomaterials

Volumn 33, Issue 27, 2012, Pages 6305-6312

  Nichols, Scott P ^a   Koh, Ahyeon ^a   Brown, Nga L ^b   Rose, Michael B ^b   Sun, Bin ^a   Slomberg, Danielle L ^a   Riccio, Daniel A ^a   Klitzman, Bruce ^b   Schoenfisch, Mark H ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biocompatibility; Foreign body response; Inflammation; Nitric oxide release; Polyurethane

Indexed keywords

ACUTE INFLAMMATORY RESPONSE; BIOMEDICAL APPLICATIONS; FOREIGN BODY RESPONSE; HISTOLOGICAL ANALYSIS; INFLAMMATION; NITRIC OXIDE RELEASE; NO RELEASE; OXIDE SURFACE; RELEASE OF NITRIC OXIDE; SUBCUTANEOUS IMPLANTS; SUBCUTANEOUS TISSUES;

BIOCOMPATIBILITY; COLLAGEN; GLUCOSE SENSORS; MEDICAL APPLICATIONS; POLYURETHANES; TISSUE;

NITRIC OXIDE;

COLLAGEN; NITRIC OXIDE; POLYURETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENCAPSULATION; FOREIGN BODY REACTION; GUIDE WIRE; HISTOPATHOLOGY; IMPLANT; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE;

ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN; FOREIGN-BODY REACTION; IMPLANTS, EXPERIMENTAL; INFLAMMATION; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NITRIC OXIDE; POLYURETHANES; SUBCUTANEOUS TISSUE; SURFACE PROPERTIES; SUS SCROFA; WATER;

SUS;

EID: 84863602536     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.053     Document Type: Article

References (56)

1. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
2. Coleman D.L., King R.N., Andrade J.D. The foreign body reaction: a chronic inflammatory response. J Biomed Mater Res 1974, 8:199-211.
3. Ratner B.D., Bryant S.J. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004, 6:41-75.
4. Klueh U., Kaur M., Qiao Y., Kreutzer D.L. Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo. Biomaterials 2010, 31:4540-4551.
5. Anderson J.M., Defife K., McNally A., Collier T., Jenney C. Monocyte, macrophage and foreign body giant cell interactions with molecularly engineered surfaces. J Mater Sci-Mater Med 1999, 10:579-588.
6. Ju Y.M., Yu B.Z., Koob T.J., Moussy Y., Moussy F. A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. I. In vitro/in vivo stability of the scaffold and in vitro sensitivity of the glucose sensor with scaffold. J Biomed Mater Res Part A 2008, 87A:136-146.
7. Ju Y.M., Yu B.Z., West L., Moussy Y., Moussy F. A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. II. Long-term in vitro/in vivo sensitivity characteristics of sensors with NDGA- or GA-crosslinked collagen scaffolds. J Biomed Mater Res Part A 2010, 92A:650-658.
8. Wang C., Yu B., Knudsen B., Harmon J., Moussy F., Moussy Y. Synthesis and performance of novel hydrogels coatings for implantable glucose sensors. Biomacromolecules 2008, 9:561-567.
9. Yu B.Z., Wang C.Y., Ju Y.M., West L., Harmon J., Moussy Y., et al. Use of hydrogel coating to improve the performance of implanted glucose sensors. Biosens Bioelectron 2008, 23:1278-1284.
10. Koh A., Nichols S.P., Schoenfisch M.H. Glucose sensor membranes for mitigating the foreign body response. J Diabetes Sci Technol 2011, 5:1052-1059.
11. Ju Y.M., Yu B.Z., West L., Moussy Y., Moussy F. A dexamethasone-loaded PLGA micirospheres/collagen scaffold composite for implantable glucose sensors. J Biomed Mater Res Part A 2010, 93A:200-210.
12. Ward W.K., Wood M.D., Casey H.M., Quinn M.J., Federiuk I.F. The effect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically implanted amperometric glucose sensor. Diabetes Technol Ther 2004, 19:155-163.
13. Patil S.D., Papadmitrakopoulos F., Burgess D.J. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release 2007, 117:68-79.
14. Norton L.W., Koschwanez H.E., Wisniewski N.A., Klitzman B., Reichert W.M. Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J Biomed Mater Res Part A 2007, 81A:858-869.
15. Edelman J.L., Lutz D., Castro M.R. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 2005, 80:249-258.
16. Machein M.R., Kullmer J., Ronicke V., Machein U., Krieg M., Damert A., et al. Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol 1999, 25:104-112.
17. Thomassen M.J., Buhrow L.T., Connors M.J., Kaneko F.T., Erzurum S.C., Kavuru M.S. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 1997, 17:279-283.
18. Schwentker A., Vodovotz Y., Weller R., Billiar T.R. Nitric oxide and wound repair: role of cytokines?. Nitric Oxide-Biol Chem 2002, 7:1-10.
19. Shukla A., Rasik A.M., Shankar R. Nitric oxide inhibits wound collagen synthesis. Mol Cell Biochem 1999, 200:27-33.
20. Schäffer M.R., Efron P.A., Thornton F.J., Klingel K., Gross S.S., Barbul A. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997, 158:2375-2381.
21. Schäffer M.R., Tantry U., Gross S.S., Wasserkrug H.L., Barbul A. Nitric oxide regulates wound healing. J Surg Res 1996, 63:237-240.
22. Thornton F.J., Schäffer M.R., Witte M.B., Moldawer L.L., MacKay S.L.D., Abouhamze A., et al. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem Biophys Res Commun 1998, 246:654-659.
23. Cooke J.P. NO and angiogenesis. Atheroscler Suppl 2003, 4:53-60.
24. Hetrick E.M., Schoenfisch M.H. Antibacterial nitric oxide-releasing xerogels: cell viability and parallel plate flow cell adhesion studies. Biomaterials 2007, 28:1948-1956.
25. Hetrick E.M., Prichard H.L., Klitzman B., Schoenfisch M.H. Reduced foreign body response at nitric oxide-releasing subcutaneous implants. Biomaterials 2007, 28:4571-4580.
26. Nichols S.P., Le N.N., Klitzman B., Schoenfisch M.H. Increased in vivo glucose recovery via nitric oxide release. Anal Chem 2011, 83:1180-1184.
27. Gifford R., Batchelor M.M., Lee Y., Gokulrangan G., Meyerhoff M.E., Wilson G.S. Mediation of in vivo glucose sensor inflammatory response via nitric oxide release. J Biomed Mater Res Part A 2005, 75A:755-766.
28. Novak M.T., Yuan F., Reichert W.M. Modeling the relative impact of capsular tissue effects on implanted glucose sensor time lag and signal attenuation. Anal Bioanal Chem 2010, 398:1695-1705.
29. Koh A., Riccio D.A., Sun B., Carpenter A.W., Nichols S.P., Schoenfisch M.H. Fabrication of nitric oxide-releasing polyurethane glucose sensor membranes. Biosens Bioelectron 2011, 28:17-24.
30. Sullivan T.P., Eaglstein W.H., Davis S.C., Mertz P. The pig as a model for human wound healing. Wound Repair Regen 2001, 9:66-76.
31. Saavedra J.E., Southan G.J., Davies K.M., Lundell A., Markou C., Hanson S.R., et al. Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem 1996, 39:4361-4365.
32. Shin J.H., Metzger S.K., Schoenfisch M.H. Synthesis of nitric oxide-releasing silica nanoparticles. J Am Chem Soc 2007, 129:4612-4619.
33. Riccio D.A., Nugent J.L., Schoenfisch M.H. Stober synthesis of nitric oxide-releasing S-nitrosothiol-modified silica particles. Chem Mat 2011, 23:1727-1735.
34. Coneski P.N., Schoenfisch M.H. Nitric oxide release: part III. Measurement and reporting. Chem Soc Rev 2012, 41:3753-3758.
35. Bancroft J., Gamble M. Theory and practice of histological techniques 2007, Churchill Livingstone, London. 6th ed.
36. Koschwanez H.E., Yap F.Y., Klitzman B., Reichert W.M. In vitro and in vivo characterization of porous poly-l-lactic acid coatings for subcutaneously implanted glucose sensors. J Biomed Mater Res Part A 2008, 87A:792-807.
37. Davila J.C., Lautsch E.V., Palmer T.E. Some physical factors affecting the acceptance of synthetic materials as tissue implants. Ann N Y Acad Sci 1968, 146:138-147.
38. Ward W.K., Slobodzian E.P., Tiekotter K.L., Wood M.D. The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants. Biomaterials 2002, 23:4185-4192.
39. Bota P.C.S., Collie A.M.B., Puolakkainen P., Vernon R.B., Sage E.H., Ratner B.D., et al. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J Biomed Mater Res Part A 2010, 95A:649-657.
40. Cao H.Q., McHugh K., Chew S.Y., Anderson J.M. The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction. J Biomed Mater Res Part A 2010, 93A:1151-1159.
41. Barbe C., Bartlett J., Kong L.G., Finnie K., Lin H.Q., Larkin M., et al. Silica particles: a novel drug-delivery system. Adv Mater 2004, 16:1959-1966.
42. Hrabie J.A., Keefer L.K. Chemistry of the nitric oxide-releasing diazeniumdiolate (" nitrosohydroxylamine" ) functional group and its oxygen-substituted derivatives. Chem Rev 2002, 102:1135-1154.
43. Davies K.M., Wink D.A., Saavedra J.E., Keefer L.K. Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J Am Chem Soc 2001, 123:5473-5481.
44. Degraaf J.C., Banga J.D., Moncada S., Palmer R.M.J., Degroot P.G., Sixma J.J. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992, 85:2284-2290.
45. Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010, 459:923-939.
46. Williams D.L.H. The chemistry of S-nitrosothiols. Acc Chem Res 1999, 32:869-876.
47. Sieminski A.L., Gooch K.J. Biomaterial-microvasculature interactions. Biomaterials 2000, 21:2233-2241.
48. Wisniewski N., Klitzman B., Miller B., Reichert W.M. Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J Biomed Mater Res 2001, 57:513-521.
49. Wilson G.S., Gifford R. Biosensors for real-time in vivo measurements. Biosens Bioelectron 2005, 20:2388-2403.
50. Jablecki M., Gough D.A. Simulations of the frequency response of implantable glucose sensors. Anal Chem 2000, 72:1853-1859.
51. Sharkawy A.A., Klitzman B., Truskey G.A., Reichert W.M. Engineering the tissue which encapsulates subcutaneous implants. 1. Diffusion properties. J Biomed Mater Res 1997, 37:401-412.
52. Wisniewski N., Reichert M. Methods for reducing biosensor membrane biofouling. Colloid Surf B Biointerfaces 2000, 18:197-219.
53. Gangjee T., Colaizzo R., Vonrecum A.F. Species-related differences in percutaneous wound-healing. Ann Biomed Eng 1985, 13:451-467.
54. Wilson G.S., Hu Y.B. Enzyme based biosensors for in vivo measurements. Chem Rev 2000, 100:2693-2704.
55. Forster J., Morris A.S., Shearer J.D., Mastrofrancesco B., Inman K.C., Lawler R.G., et al. Glucose-uptake and flux through phosphofructokinase in wounded rat skeletal-muscle. Am J Physiol 1989, 256:E788-E797.
56. Zhao Q.H., McNally A.K., Rubin K.R., Renier M., Wu Y., Rosecaprara V., et al. Human plasma alpha-2-macroglobulin promotes in vitro oxidative stress cracking of pellethane-2363-80A - in vivo and in vitro correlations. J Biomed Mater Res 1993, 27:379-389.